TB Summit 2014

TB Summit 2014

After last year’s success at organizing a meeting to commemorate World Tuberculosis (TB) Day, Euroscicon expanded its scope to include in-depth discussions on the latest advancements in the prevention, diagnosis and treatment of TB, over a threeday long (24th March – 26th March) international conference. It was a well-attended conference comprising of about 30 oral and poster presentations of p...

Proceedings of 2014 Stillbirth Summit

Stillbirth is a devastating pregnancy outcome that occurs once in every 160 pregnancies in the United States, [1] with similar rates in other developed nations around the world. Despite advances in medical knowledge and technology, there have been slow trends in stillbirth reduction in most high income countries over the past two decades relative to other declines in infant mortality [2]. Contr...

Proceedings of the Stillbirth Summit 2014.

Tackling tuberculosis: Insights from an international TB Summit in London

Tuberculosis (TB) poses a grave predicament to the world as it is not merely a scientific challenge but a socio-economic burden as well. A prime cause of mortality in human due to an infectious disease; the malady and its cause, Mycobacterium tuberculosis have remained an enigma with many questions that remain unanswered. The ability of the pathogen to survive and switch between varied physiolo...

World TB Day — March 24, 2014

234 Implementation of New TB Screening Requirements for U.S.-Bound Immigrants and Refugees — 2007–2014 237 Combined Use of Inactivated and Oral Poliovirus Vaccines in Refugee Camps and Surrounding Communities — Kenya, December 2013 242 Update on Vaccine-Derived Polioviruses — Worldwide, July 2012–December 2013 249 Notes from the Field: A Cluster of Lymphocytic Choriomeningitis Virus Infections ...